Abbott Laboratories Aktie

112,03USD 0,13USD 0,12%
Abbott Laboratories hier für 0 Euro handeln mit finanzen.net zero
WKN: 850103 / ISIN: US0028241000
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 97,92

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2017 2018 2019 2020 2021
Personal am Ende des Jahres 99 000 103 000 107 000 109 000 113 000
Umsatz pro Mitarbeiter in Mio. EUR 0,28 0,30 0,30 0,32 0,38

Bilanz (in Mio. EUR) - Aktiva

2017 2018 2019 2020 2021
Summe Umlaufvermögen 20 147 14 632 15 667 20 441 24 239
Summe Anlagevermögen 58 821 50 090 50 187 52 674 55 053
Summe Aktiva 76 250 67 173 67 887 72 548 75 196

Bilanz (in Mio. EUR) - Passiva

2017 2018 2019 2020 2021
Gesamtverschuldung/ -verbindlichkeiten 27 924 19 566 19 099 19 890 19 251
Summe Fremdkapital 45 152 36 451 36 586 39 545 39 172
Summe Eigenkapital 31 098 30 722 31 301 33 003 36 024
Summe Passiva 76 250 67 173 67 887 72 548 75 196

Adresse

100 Abbott Park Road, 60064-6400 Abbott Park
Telefon +1 (224) 667-6100
Internet http://www.abbott.com

Management

Andrea F. Wainer
Executive VP-Rapid & Molecular Diagnostics
Daniel Gesua Sive Salvadori
Executive Vice President-Nutritional Products
Daniel J. Starks
Independent Director
Darren W. McDew
Independent Director
David P. Mark
Vice President-Internal Audit
Gene Huang
Chief Economist & Vice President
Glenn Fletcher Tilton
Independent Director
Hubert L. Allen
Secretary, Executive VP & General Counsel
Jim Leffelman
Manager-Expense Reporting
John G. Stratton
Independent Director
John M. Capek
Executive Vice President-Ventures
Karen Chayavirabood
Regional Director-Asia
Karen Peterson
Treasurer & Vice President
Kathryn S. Collins
Vice President-Commercial Legal Operations
Lisa D. Earnhardt
Executive Vice President-Medical Devices
Mary K. Moreland
Executive Vice President-Human Resources
Melissa Brotz
Vice President-Global Marketing & External Affairs
Michael F. Roman
Independent Director
Michelle A. Kumbier
Independent Director
Nancy McKinstry
Independent Director
Paola Gonzalez
Independent Director
Philip P. Boudreau
Vice President-Finance & Controller
Randel William Woodgrift
Vice President-Global Operations & Cardiovascular
Robert B. Ford
Chairman, President, Chief Executive Officer & COO
Robert Emmett Funck
Chief Financial Officer & Executive VP-Finance
Robert J. Alpern
Independent Director
Sabina Ewing
Chief Investment Officer, VP-Business & Technology
Sally E. Blount
Independent Director
Scott J. House
Senior Vice President-Regulatory Services
Scott Leinenweber
Vice President-Investor Relations
William A. Osborn
Lead Independent Director